Brigimadlin (BI 907828) is an orally active E3 ubiquitin-protein ligase MDM-2 inhibitor, preventing MDM-2 from negatively regulating the tumor suppressor p53. Brigimadlin can be used for antineoplastic research[1][2][3][4].
Molecular Weight:
591.46
Purity:
99.88
CAS Number:
[2095116-40-6]
Formula:
C31H25Cl2FN4O3
Target:
E1/E2/E3 Enzyme,MDM-2/p53
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted